Metraipolis › archive › dc_d760072d477b

Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance — Europe PMC PMID:41876444

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41876444
DOI
10.71150/jm.2510019
License (as archived)
solo-consultazione
Archived
2026-10-17T15:38:11.508Z
SHA-256 of the archived text
708d9565fd586a62d8d66d96ea1efeeb23fb9352e53262765ea02f5b50a4c938
Stable URL of this page
https://metraipolis.com/documento/dc_d760072d477b

How to cite

Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance — Europe PMC PMID:41876444 — Europe PMC (en), https://europepmc.org/article/MED/41876444 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d760072d477b (Metraipolis archive dc_d760072d477b, sha256 708d9565fd586a62d8d66d96ea1efeeb23fb9352e53262765ea02f5b50a4c938)
BibTeX
@misc{dcd760072d477b,
  title = {Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance — Europe PMC PMID:41876444},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41876444},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d760072d477b; sha256 708d9565fd586a62d8d66d96ea1efeeb23fb9352e53262765ea02f5b50a4c938},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41876444. Agents can read the archived copy with the MCP tool read_document.